1.Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy.
Young Sun SUH ; Seung Ki KWOK ; Ji Hyeon JU ; Kyung Su PARK ; Sung Hwan PARK ; Chong Hyeon YOON
Journal of Korean Medical Science 2014;29(1):38-42
There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFalpha) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of TNFalpha inhibitors due to active tuberculosis (TB). We evaluated the safety of restarting anti-TNFalpha therapy in patients with TNFalpha-associated TB. We used data of 1,012 patients with RA or AS treated with TNFalpha inhibitors at Seoul St. Mary's Hospital between January 2003 and July 2013 to identify patients who developed active TB. Demographic and clinical data including the results of tuberculin skin tests (TST) and interferon-gamma releasing assays (IGRA) were collected. Fifteen patients developed active TB. Five cases were occurred in RA and 10 cases in AS. Nine of 15 patients had a negative TST or IGRA and 6 TST-positive patients had received prophylaxis prior to initiating anti-TNFalpha therapy. All patients discontinued TNFalpha inhibitors with starting the treatment of TB. Eight patients were re-administered TNFalpha inhibitors due to disease flares and promptly improved without recurrence of TB. TNFalpha inhibitors could be safely resumed after starting anti-TB regimen in patients with RA or AS.
Adult
;
Aged
;
Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use
;
Antibodies, Monoclonal/adverse effects/therapeutic use
;
Antibodies, Monoclonal, Humanized/adverse effects/therapeutic use
;
Antirheumatic Agents/adverse effects/therapeutic use
;
Arthritis, Rheumatoid/*drug therapy
;
Enzyme Inhibitors/adverse effects/therapeutic use
;
Female
;
Humans
;
Hydroxychloroquine/adverse effects/therapeutic use
;
Immunoglobulin G/adverse effects/therapeutic use
;
Immunosuppressive Agents/adverse effects/*therapeutic use
;
Interferon-gamma Release Tests
;
Male
;
Methotrexate/adverse effects/therapeutic use
;
Middle Aged
;
Mycobacterium tuberculosis/isolation & purification
;
Receptors, Tumor Necrosis Factor/therapeutic use
;
Retrospective Studies
;
Spondylitis, Ankylosing/*drug therapy
;
Tuberculin Test
;
Tuberculosis/*chemically induced/microbiology
;
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
2.Human Papillomavirus Prevalence and Genotype Distribution among HIV-Infected Women in Korea.
Eun Kyoung PARK ; Heerim CHO ; Sun Hee LEE ; Seung Geun LEE ; Sang Yeup LEE ; Ki Hyung KIM ; Chang Hun LEE ; Joo Seop CHUNG ; Ihm Soo KWAK
Journal of Korean Medical Science 2014;29(1):32-37
The epidemiology on human papillomavirus (HPV) among human immunodeficiency virus (HIV)-infected women in Korea is not well established. A retrospective study was conducted to determine the prevalence and genotype distribution of HPV infection among HIV-infected women in Korea. HPV DNA genotype and cervical cytology were examined in 60 HIV-positive women and 1,938 HIV-negative women. HPV genotypes were analyzed by using a HPV DNA chip. HIV-infected women had higher prevalence of high-risk HPV (hr-HPV) infection (30% vs 4.9%, adjusted odds ratio [AOR], 6.96; 95% confidence interval [CI], 3.63-13.34, P<0.001) and abnormal cervical cytology (18.3% vs 1.8%, AOR, 10.94; 95% CI, 5.18-23.1, P<0.001) compared with controls. The most common hr-HPV genotype detected in HIV-infected women was HPV 16 (10%), followed by 18 (6.7%) and 52 (5%). Prevalence of quadrivalent vaccine-preventable types (HPV 6, 11, 16, and 18) was 21.7% and 2.3% in HIV-positive women and HIV-negative women, respectively. Age was a significant risk factor for hr-HPV infection in HIV-infected women (P=0.039). The presence of hr-HPV was significantly associated with abnormal cervical cytology (P<0.001). These findings suggest that HPV testing for cervical cancer screening in HIV-infected women would be necessary, particularly among young age group.
Adult
;
Age Factors
;
Cervix Uteri/virology
;
DNA Probes, HPV/diagnostic use
;
DNA, Viral/genetics
;
Female
;
Genotype
;
HIV Infections/complications/*epidemiology/genetics
;
HIV-1/genetics
;
Human papillomavirus 11/genetics/isolation & purification
;
Human papillomavirus 16/genetics/isolation & purification
;
Human papillomavirus 18/genetics/isolation & purification
;
Human papillomavirus 6/genetics/isolation & purification
;
Humans
;
Middle Aged
;
Papillomavirus Infections/complications/*epidemiology/*genetics
;
Prevalence
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk Factors
;
Uterine Cervical Neoplasms/epidemiology/genetics/virology
3.A Randomized, Open-Label, Multicenter Trial for the Safety and Efficacy of Adult Mesenchymal Stem Cells after Acute Myocardial Infarction.
Jun Won LEE ; Seung Hwan LEE ; Young Jin YOUN ; Min Soo AHN ; Jang Young KIM ; Byung Su YOO ; Junghan YOON ; Woocheol KWON ; In Soo HONG ; Kyounghoon LEE ; Jun KWAN ; Keum Soo PARK ; Donghoon CHOI ; Yang Soo JANG ; Mun K HONG
Journal of Korean Medical Science 2014;29(1):23-31
Recent studies suggest that the intracoronary administration of bone marrow (BM)-derived mesenchymal stem cells (MSCs) may improve left ventricular function in patients with acute myocardial infarction (AMI). However, there is still argumentative for the safety and efficacy of MSCs in the AMI setting. We thus performed a randomized pilot study to investigate the safety and efficacy of MSCs in patients with AMI. Eighty patients with AMI after successful reperfusion therapy were randomly assigned and received an intracoronary administration of autologous BM-derived MSCs into the infarct related artery at 1 month. During follow-up period, 58 patients completed the trial. The primary endpoint was changes in left ventricular ejection fraction (LVEF) by single-photon emission computed tomography (SPECT) at 6 month. We also evaluated treatment-related adverse events. The absolute improvement in the LVEF by SPECT at 6 month was greater in the BM-derived MSCs group than in the control group (5.9%+/-8.5% vs 1.6%+/-7.0%; P=0.037). There was no treatment-related toxicity during intracoronary administration of MSCs. No significant adverse cardiovascular events occurred during follow-up. In conclusion, the intracoronary infusion of human BM-derived MSCs at 1 month is tolerable and safe with modest improvement in LVEF at 6-month follow-up by SPECT. (ClinicalTrials.gov registration number: NCT01392105)
Adult
;
Aged
;
Bone Marrow Cells/cytology
;
Cell- and Tissue-Based Therapy/*adverse effects
;
Echocardiography
;
Female
;
Heart/physiopathology
;
Humans
;
Male
;
Mesenchymal Stem Cell Transplantation/*adverse effects
;
Mesenchymal Stromal Cells/*cytology
;
Middle Aged
;
Myocardial Infarction/*therapy
;
Pilot Projects
;
Stroke Volume
;
Tomography, Emission-Computed, Single-Photon
;
Transplantation, Autologous
;
Treatment Outcome
;
Ventricular Function, Left
;
Young Adult
4.Evidence-Based, Non-Pharmacological Treatment Guideline for Depression in Korea.
Seon Cheol PARK ; Hong Seok OH ; Dong Hoon OH ; Seung Ah JUNG ; Kyoung Sae NA ; Hwa Young LEE ; Ree Hun KANG ; Yun Kyeung CHOI ; Min Soo LEE ; Yong Chon PARK
Journal of Korean Medical Science 2014;29(1):12-22
Although pharmacological treatment constitutes the main therapeutic approach for depression, non-pharmacological treatments (self-care or psychotherapeutic approach) are usually regarded as more essential therapeutic approaches in clinical practice. However, there have been few clinical practice guidelines concerning self-care or psychotherapy in the management of depression. This study introduces the 'Evidence-Based, Non-Pharmacological Treatment Guideline for Depression in Korea.' For the first time, a guideline was developed for non-pharmacological treatments for Korean adults with mild-to-moderate depression. The guideline development process consisted of establishing several key questions related to non-pharmacologic treatments of depression, searching the literature for studies which answer these questions, assessing the evidence level of each selected study, drawing up draft recommendation, and peer review. The Scottish Intercollegiate Guidelines Network grading system was used to evaluate the quality of evidence. As a result of this process, the guideline recommends exercise therapy, bibliotherapy, cognitive behavior therapy, short-term psychodynamic supportive psychotherapy, and interpersonal psychotherapy as the non-pharmacological treatments for adult patients with mild-to-moderate depression in Korea. Hence, it is necessary to develop specific methodologies for several non-pharmacological treatment for Korean adults with depression.
Adult
;
Bibliotherapy/*methods
;
Clinical Protocols
;
Cognitive Therapy/*methods
;
Combined Modality Therapy/*methods
;
Depression/*drug therapy/psychology/*therapy
;
Exercise Therapy
;
Humans
;
Placebos/therapeutic use
;
Questionnaires
;
Republic of Korea
5.Role of Endoplasmic Reticulum Stress in Rheumatoid Arthritis Pathogenesis.
Yune Jung PARK ; Seung Ah YOO ; Wan Uk KIM
Journal of Korean Medical Science 2014;29(1):2-11
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by abnormal proliferation of synoviocytes, leukocyte infiltration, and angiogenesis. The endoplasmic reticulum (ER) is the site of biosynthesis for all secreted and membrane proteins. The accumulation of unfolded proteins in the ER leads to a condition known as ER stress. Failure of the ER's adaptive capacity results in abnormal activation of the unfolded protein response. Recently, we have demonstrated that ER stress-associated gene signatures are highly expressed in RA synovium and synovial cells. Mice with Grp78 haploinsufficiency exhibit the suppression of experimentally induced arthritis, suggesting that the ER chaperone GRP78 is crucial for RA pathogenesis. Moreover, increasing evidence has suggested that GRP78 participates in antibody generation, T cell proliferation, and pro-inflammatory cytokine production, and is therefore one of the potential therapeutic targets for RA. In this review, we discuss the putative, pathophysiological roles of ER stress and GRP78 in RA pathogenesis.
Animals
;
Arthritis, Rheumatoid/genetics/*pathology
;
Autoantibodies/immunology
;
Cell Proliferation
;
Cytokines/biosynthesis/immunology
;
Endoplasmic Reticulum/immunology/pathology
;
Endoplasmic Reticulum Stress/*immunology
;
Haploinsufficiency/genetics
;
Heat-Shock Proteins/*genetics/*immunology
;
Humans
;
Lymphocyte Activation
;
Mice
;
Neovascularization, Pathologic/genetics
;
Protein Folding
;
Synovial Membrane/cytology
;
T-Lymphocytes/immunology
;
Unfolded Protein Response/*immunology
6.Launching a New Section for the Journal of Korean Medical Science: Focusing on Editing, Writing, and Publishing Issues.
Journal of Korean Medical Science 2014;29(1):1-1
No abstract available.
*Editorial Policies
;
Humans
;
Peer Review
;
*Publishing
;
*Writing
7.A Novel Mutation (A148V) in the Glucose 6-phosphate Translocase (SLC37A4) Gene in a Korean Patient with Glycogen Storage Disease Type 1b.
Sung Hee HAN ; Chang Seok KI ; Ji Eun LEE ; Young Jin HONG ; Byong Kwan SON ; Kyung Hee LEE ; Yon Ho CHOE ; Soo Youn LEE ; Jong Won KIM
Journal of Korean Medical Science 2005;20(3):499-501
We report a Korean patient with glycogen storage disease type 1b (GSD-1b) whose diagnosis was confirmed by liver biopsy and laboratory results. The patient presented with delay of puberty and short stature on admission and had typical clinical symptoms of GSD as well as chronic neutropenia and inflammatory bowel disease. Mutation analysis of the glucose 6-phosphate translocase 6-phosphate translocase (SLC37A4) gene revealed that the patient was a compound heterozygote of two different mutations including a deletion mutation (c.1042_1043delCT; L348fs) and a missense mutation (A148V). The L348fs mutation was inherited from the patient's father and has been reported in an Italian family with GSD-1b, while the A148V mutation was transmitted from the patient's mother and was a novel mutation. To the best of our knowledge, this is the first report of genetically confirmed case of GSD-1b in Korean.
Base Sequence
;
DNA/chemistry/genetics
;
DNA Mutational Analysis
;
Glycogen Storage Disease Type I/enzymology/*genetics
;
Humans
;
Korea
;
*Mutation, Missense
;
Phosphotransferases/*genetics
;
Research Support, Non-U.S. Gov't
8.Association of Vitamin D Receptor Gene Polymorphism and Parkinson's Disease in Koreans.
Joong Seok KIM ; Yeong In KIM ; Christopher SONG ; Injin YOON ; Jeong Wook PARK ; Young Bin CHOI ; Hee Tae KIM ; Kwang Soo LEE
Journal of Korean Medical Science 2005;20(3):495-498
1alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3), which is the biologically active form of vitamin D, has anti-inflammatory effects and can prevent experimental Parkinson's disease (PD). 1,25(OH)2D3 exerts most of its actions only after it binds to its specific nuclear receptors. Eighty-five Korean patients with PD and 231 unrelated healthy individuals were evaluated to determine if vitamin D receptor gene (VDRG) BsmI polymorphisms were markers for the susceptibility to PD in Korean patients. Each polymorphism was detected using polymerase chain reaction (PCR)-based restriction analysis. In addition, the relationship between the BsmI polymorphisms and the clinical manifestations of PD was evaluated. Overexpression of the b allele (91.2 vs. 85.7%; p=0.069) and homozygote bb (84.7 vs. 72.7%; p=0.043) was found in the PD patients compared with the controls. These results show for the first time an association between PD and a VDRG polymorphism, which might be involved in the pathogenesis of PD, or in the linkage disequilibrium of the VDRG to another pathogenic gene locus.
Aged
;
Alleles
;
DNA/genetics/metabolism
;
Deoxyribonucleases, Type II Site-Specific/metabolism
;
Female
;
Gene Frequency
;
Genotype
;
Humans
;
Korea
;
Linkage Disequilibrium
;
Male
;
Middle Aged
;
Parkinson Disease/*genetics
;
*Polymorphism, Genetic
;
Receptors, Calcitriol/*genetics
9.Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma.
Kyung Il PAEK ; Seon Hwan KIM ; Shi Hun SONG ; Seung Won CHOI ; Hyeon Song KOH ; Jin Young YOUM ; Youn KIM
Journal of Korean Medical Science 2005;20(3):489-494
The aim of our study was to investigate the correlation of the proliferative activity of pituitary neoplasms with clinical characteristics and recurrences. Tumor specimens were obtained from 44 consecutive patients with pituitary macroadenomas who underwent surgery between July 1998 and August 2003. Specimens were immediately fixed in 10% buffered formalin and then embedded in paraffin. The Ki-67 antigen was assessed by immumohistochemical analysis using the monoclonal antibody. We investigated the correlation of the Ki-67 labeling index with the following clinical and radiological characteristics: sex, age, presence or absence visual field defect, tumor classification, maximal tumor diameter, Hardy's classification, type of tumor, invasiveness, and recurrence. Our study suggests that the clinical characteristics such as visual field defect and recurrence are correlated with the high Ki-67 labeling index. No statistical differences were observed in the Ki-67 labeling index in relation to the following characteristics: sex, age, tumor classification, maximal tumor diameter, Hardy's classification, type of tumor, and invasiveness into the sphenoid sinus or cavernous sinus.
Adenoma/metabolism/*pathology/radiography
;
Adult
;
Aged
;
Comparative Study
;
Female
;
Humans
;
Immunohistochemistry
;
Ki-67 Antigen/*analysis
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Pituitary Neoplasms/metabolism/*pathology/radiography
10.Development of Korean Standard Brain Templates.
Jae Sung LEE ; Dong Soo LEE ; Jinsu KIM ; Yu Kyeong KIM ; Eunjoo KANG ; Hyejin KANG ; Keon Wook KANG ; Jong Min LEE ; Jae Jin KIM ; Hae Jeong PARK ; Jun Soo KWON ; Sun I KIM ; Tae Woo YOO ; Kee Hyun CHANG ; Myung Chul LEE
Journal of Korean Medical Science 2005;20(3):483-488
We developed age, gender and ethnic specific brain templates based on MR and Positron-Emission Tomography (PET) images of Korean normal volunteers. Seventy-eight normal right-handed volunteers (M/F=49/29) underwent 3D T1-weighted SPGR MR and F-18-FDG PET scans. For the generation of standard templates, an optimal target brain that has the average global hemispheric shape was selected for each gender. MR images were then spatially normalized by linear transformation to the target brains, and normalization parameters were reapplied to PET images. Subjects were subdivided into 2 groups for each gender: the young/midlife (<55 yr) and the elderly groups. Young and elderly MRI/PET templates were composed by averaging the spatially normalized images. Korean templates showed different shapes and sizes (mean length, width, and height of the brains were 16.5, 14.3 and 12.1 cm for man, and 15.6, 13.5 and 11.4 cm for woman) from the template based on Caucasian (18.3, 14.2, and 13.3 cm). MRI and PET templates developed in this study will provide the framework for more accurate stereotactic standardization and anatomical localization.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Brain/*radiography/*radionuclide imaging
;
Comparative Study
;
Female
;
Fluorodeoxyglucose F18/diagnostic use
;
Humans
;
Korea
;
Magnetic Resonance Imaging/methods
;
Male
;
Middle Aged
;
Positron-Emission Tomography/methods
;
Research Support, Non-U.S. Gov't
;
Sex Factors